Owners, management and financials
CVR: 41372079
DKK -14,000
Gross profit
Net result: DKK -14,000
OMX Ventures Fund I, LLC (5-9,99%), Sofinnova Capital IX (5-9,99%)
4 more
CVR · view owners
Colleen Denise Acosta
Board: Peter Finsel Bisgaard (chair) and 6 members
CVR · view management
Active
Founded 19 May 2020
CVR · view overview
No headcount reported
Owner registered: Bill & Melinda Gates Foundation
CVR · 03/12/2025
View the full event history
Freya Biosciences License ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Colleen Denise Acosta. The board consists of Peter Finsel Bisgaard (chair), Claudia Maria Colciago, Colleen Denise Acosta and David Lawrence Stern. The company's owners include OMX Ventures Fund I, LLC, Sofinnova Capital IX and Danmarks Eksport- og Investeringsfond. In 2025, the company reported a gross profit of DKK -14,000 and a net result of DKK -14,000 compared with DKK -30,358 the year before. Equity in the 2025 report amounted to DKK 357,000.
Selskabets formål er at udvikle og drive virksomhed inden for handel med farmaceutiske produkter og udstyr samt anden i forbindelse hermed stående virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -14 t. | 479 t. | 357 t. | - | |
| 202401/01/2024 – 31/12/2024 | - | -30 t. | 437 t. | 316 t. | - | |
| 202301/01/2023 – 31/12/2023 | - | -24 t. | 257 t. | 195 t. | - | |
| 202201/01/2022 – 31/12/2022 | - | -48 t. | 172 t. | 105 t. | - | |
| 202101/01/2021 – 31/12/2021 | 0 | -38 t. | 37 t. | 19 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Freya Biosciences License ApS is 41372079.
The owners of Freya Biosciences License ApS include OMX Ventures Fund I, LLC, Sofinnova Capital IX and Danmarks Eksport- og Investeringsfond.
The management of Freya Biosciences License ApS consists of Colleen Denise Acosta.
The board of Freya Biosciences License ApS consists of Peter Finsel Bisgaard, Claudia Maria Colciago and Colleen Denise Acosta, with Peter Finsel Bisgaard as chair.
In 2025, Freya Biosciences License ApS reported a gross profit of DKK -14,000.
Freya Biosciences License ApS was founded on 19 May 2020.
Claim this page to add your logo and social links. Free to get started.
Freya Biosciences License ApS has published its annual report for 2025. Gross profit came to DKK -14,000, and the net result was DKK -14,000.
As of December 3, 2025, is registered as an owner of Freya Biosciences License ApS with an ownership share of 15%.
Freya Biosciences License ApS has published its annual report for 2024. Gross profit came to DKK -30,358, and the net result was DKK -30,358.
As of September 30, 2024, David Lawrence Stern has joined the board of directors of Freya Biosciences License ApS.
As of September 30, 2024, is registered as an owner of Freya Biosciences License ApS with an ownership share of 5%.
As of September 30, 2024, is registered as an owner of Freya Biosciences License ApS with an ownership share of 5%.
As of September 30, 2024, Danmarks Eksport- og Investeringsfond is registered as an owner of Freya Biosciences License ApS with an ownership share of 10%.
Freya Biosciences License ApS has published its annual report for 2023. Gross profit came to DKK -24,000, and the net result was DKK -24,000.
Freya Biosciences License ApS has published its annual report for 2022. Gross profit came to DKK -48,000, and the net result was DKK -48,000.
As of February 20, 2023, Claudia Maria Colciago has joined the board of directors of Freya Biosciences License ApS.
As of February 20, 2023, is registered as an owner of Freya Biosciences License ApS with an ownership share of 20%.
As of February 20, 2023, is registered as an owner of Freya Biosciences License ApS with an ownership share of 5%.
Freya Biosciences License ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -37,500.
As of October 7, 2022, Peter Finsel Bisgaard has joined the board of directors of Freya Biosciences License ApS.
As of October 7, 2022, Henrijette Elsebeth Richter has joined the board of directors of Freya Biosciences License ApS.
As of October 7, 2022, Colleen Denise Acosta has joined the board of directors of Freya Biosciences License ApS.
As of October 7, 2022, Nicholas Haft has joined the board of directors of Freya Biosciences License ApS.
As of October 7, 2022, Mark Smith has joined the board of directors of Freya Biosciences License ApS.
As of October 7, 2022, Colleen Denise Acosta is registered as adm. dir. of Freya Biosciences License ApS.
As of October 7, 2022, Lars Skanvig Bramhelft has stepped down as liquidator of Freya Biosciences License ApS.
On October 7, 2022, Freya Biosciences License ApS exited liquidation.
As of September 12, 2022, Lars Skanvig Bramhelft is registered as liquidator of Freya Biosciences License ApS.
On September 12, 2022, Freya Biosciences License ApS entered liquidation.
As of August 18, 2022, Peter Finsel Bisgaard has left the board of directors of Freya Biosciences License ApS.
As of August 18, 2022, Henrijette Elsebeth Richter has left the board of directors of Freya Biosciences License ApS.
As of August 18, 2022, Colleen Denise Acosta has left the board of directors of Freya Biosciences License ApS.
As of August 18, 2022, Mark Smith has left the board of directors of Freya Biosciences License ApS.
As of August 18, 2022, Colleen Denise Acosta has stepped down as adm. dir. of Freya Biosciences License ApS.
Freya Biosciences License ApS has published its interim report for the period May 19, 2020 – December 31, 2020.
As of August 18, 2020, Nicholas Haft has left the board of directors of Freya Biosciences License ApS.
As of August 12, 2020, Henrijette Elsebeth Richter has joined the board of directors of Freya Biosciences License ApS.
As of August 12, 2020, Colleen Denise Acosta has joined the board of directors of Freya Biosciences License ApS.
As of August 12, 2020, Nicholas Haft has joined the board of directors of Freya Biosciences License ApS.
As of August 12, 2020, Mark Smith has joined the board of directors of Freya Biosciences License ApS.
As of August 12, 2020, Thomas Gundelund Rasmussen has left the board of directors of Freya Biosciences License ApS.
As of August 12, 2020, Johannes Epeüs Theodoor van Hylckama Vlieg has left the board of directors of Freya Biosciences License ApS.
As of May 19, 2020, Peter Finsel Bisgaard has joined the board of directors of Freya Biosciences License ApS.
As of May 19, 2020, Thomas Gundelund Rasmussen has joined the board of directors of Freya Biosciences License ApS.
As of May 19, 2020, Johannes Epeüs Theodoor van Hylckama Vlieg has joined the board of directors of Freya Biosciences License ApS.
As of May 19, 2020, Colleen Denise Acosta is registered as adm. dir. of Freya Biosciences License ApS.
Freya Biosciences License ApS was founded on May 19, 2020.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at drive forretning med digital markedsføring og strategi samt enhver i forbindelse hermed stående virksomhed.
Companies in the same industry and area
CVR 37812730
CVR 39315769
CVR 40169229
CVR 41257547
CVR 44931478
